SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently trending as rising Treasury yields and persistent inflation concerns, exacerbated by geopolitical tensions in the Middle East, continue to pressure the long-term bond market. Investors are actively discussing the potential for a systemic crisis if long-term yields break higher, while some market participants interpret the current volatility as a strategic entry point for fixed income and a hedge against a potential equity market correction.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors weigh conflicting macroeconomic signals, including rising interest rates and geopolitical tensions, against long-term concerns over global debt levels and central bank accumulation. The community remains divided, with some traders citing the asset as essential for portfolio protection against inflation, while others point to institutional outflows and technical resistance as indicators of a potentially extended consolidation period.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Health is trending as market attention focuses on recent insider buying activity and anticipation surrounding upcoming earnings, despite ongoing community frustration regarding long-term debt and the stagnant performance of spin-off assets. Traders are closely monitoring these developments as a potential catalyst for a re-rating, though sentiment remains polarized between those betting on an eventual turnaround and others wary of historical price volatility.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is experiencing increased market momentum and community optimism driven by the recent launch of its second-generation driverless trucks and ongoing expansion of commercial partnerships. Investors are closely monitoring the stock for potential institutional buying and scaling milestones, with many users focused on the company's long-term commercialization strategy despite concerns from short-sellers regarding capital burn and market volatility.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is surging as the RWA sector sees renewed momentum, with community members closely tracking the potential passage of the Clarity Act and ongoing institutional interest in tokenized assets. Investors remain hyper-focused on the project's leadership in the tokenization space, while debating the impact of future governance votes on long-term token value.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending following reports of advanced acquisition talks with Delivery Hero, a move intended to significantly scale its global food delivery operations and challenge sector rivals. Despite community excitement over potential long-term growth and market dominance, the stock is seeing heightened volatility as investors debate the costs of integration and the risks associated with recent autonomous vehicle partnership developments.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF (GDX) is trending as the community debates whether recent volatility represents a structural bottom or a temporary consolidation within a larger commodities cycle. Investors are closely monitoring geopolitical instability, persistent inflation, and central bank physical gold accumulation as key catalysts that could drive a long-term upward trajectory despite short-term price pressure.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors debate its valuation, potential acquisition appeal to tech giants, and strategic expansion into international and autonomous ride-hailing partnerships. Community discussion remains polarized, focusing on a high short interest, recent insider buying, and the stock's sluggish price performance compared to its earnings growth.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is seeing a wave of market interest alongside other utility-focused assets, driven by community speculation regarding potential enterprise adoption and its role in tokenization infrastructure. Investors are actively debating the timing of long-term catalysts, with many focusing on accumulation strategies and the potential for a broader shift in institutional momentum.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is capturing significant community attention as investors finalize their monthly dividend strategies, with many using the recent market volatility to accumulate shares for long-term income. Discussions are centered on comparing its Nasdaq-linked performance and payout consistency against other popular income funds, while loyal holders continue to favor the ETF as a core component for building a sustainable monthly cash flow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LEGN Stock Plunges 15% After Sudden CEO Exit — But Analyst Reiterates Optimism In Company’s Under-Development Lymphoma Asset 

Equity

Legend said on Monday that Ying Huang stepped down as chief executive officer and board member effective July 24. 


Sellas CEO Angelos Stergiou Says ‘100% Certain’ AI Can Be Used To Beat Cancer 

public companies

During an interview on Fox & Friends on Friday, Stergiou said AI will play a major role in helping cure cancer by enabling more precise treatments.

OTLK Stock Generates Buzz Ahead Of FDA Decision On Wet AMD Therapy – Retail Says Favorable Verdict Could Cause A ‘Big Boom’

After two rejections, retail investors are hopeful the FDA will approve Outlook Therapeutics’ Lytenava for the treatment of wet AMD.


VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

Wall Street sees bigger upside in VKTX, with Koyfin’s average target implying 120% upside versus 99% for BCRX.

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

Multiple analysts reiterated optimism on CMPS stock after the company announced 26-week data from its second late-stage trial of COMP360 in treatment-resistant depression.


AGIO Stock Hits Over 7-Month Highs – FDA Catalyst, ‘Seasonally Strong’ Q2 Earnings Estimate Drive Optimism

Agios said the U.S. Food and Drug Administration granted Priority Review to its supplemental new drug application for Mitapivat in sickle cell disease.

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns 

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 


ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

Abivax said the findings strengthen the overall case for obefazimod and reinforce its favorable benefit-risk profile.


Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know

Larimar submitted the module of a rolling biologics license application to the U.S. Food and Drug Administration for the accelerated approval of nomlabofusp for Friedreich’s ataxia.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

iShares Trust - iShares Biotechnology ETF

Neutral Sentiment

< 1 yr

1 - 3 yrs

3 - 10 yrs

10+ yrs

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&P Global

Feed

News

Sentiment

Fundamentals

Info